We are live on
!
Find out more
BBHC
Brown Brothers Harriman & Co Portfolio holdings
AUM
$22.8B
1-Year Est. Return
25.09%
This Fund
S&P 500
This Quarter
Est. Return
+8.93%
1 Year Est. Return
+25.09%
3 Year Est. Return
+81.82%
5 Year Est. Return
+99.92%
10 Year Est. Return
+339.81%
AUM
$12.4B
AUM Growth
+$492M
(+4.1%)
Cap. Flow
-$416M
Cap. Flow
% of AUM
-3.35%
Top 10 Holdings %
Top 10 Hldgs %
38.46%
Holding
1,359
New
99
Increased
208
Reduced
410
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$48M |
| 2 |
Carlisle Companies
CSL
|
+$46.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$22.1M |
| 4 |
KLA
KLAC
|
+$16.7M |
| 5 |
Medtronic
MDT
|
+$14.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celanese
CE
|
+$84M |
| 2 |
Booking.com
BKNG
|
+$61.1M |
| 3 |
Mastercard
MA
|
+$59.2M |
| 4 |
Graco
GGG
|
+$51.1M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.16% |
| 2 | Technology | 19.04% |
| 3 | Healthcare | 14.22% |
| 4 | Industrials | 13.7% |
| 5 | Consumer Staples | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Prime Medicine
PRME
$575M
| $147K | ﹤0.01% |
+10,065
| New | +$141K |
|
527
Citigroup
C
$233B
| $147K | ﹤0.01% |
3,190
-24,806
| -89% | -$1.16M |
|
528
Ares Capital
ARCC
$14.5B
| $146K | ﹤0.01% |
7,794
+450
| +6% | +$8.31K |
|
529
Old Republic International
ORI
$10.3B
| $144K | ﹤0.01% |
5,705
-3,424
| -38% | -$85.8K |
|
|
DSKE
530
DELISTED
Daseke, Inc. Common Stock
DSKE
| $143K | ﹤0.01% |
20,000
| – | – |
|
531
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $142K | ﹤0.01% |
1,570
| – | – |
|
532
Canadian National Railway
CNI
$77.2B
| $141K | ﹤0.01% |
1,168
| – | – |
|
533
WisdomTree US SmallCap Dividend Fund
DES
$2.23B
| $139K | ﹤0.01% |
4,828
| – | – |
|
534
Global X Lithium & Battery Tech ETF
LIT
$1.6B
| $138K | ﹤0.01% |
2,129
+217
| +11% | +$13.5K |
|
535
Archer Daniels Midland
ADM
$38.7B
| $138K | ﹤0.01% |
1,831
-5
| -0.3% | -$379 |
|
536
Crane NXT
CXT
$2.94B
| $138K | ﹤0.01% |
2,442
-4,589
| -65% | -$233K |
|
|
EA
537
DELISTED
Electronic Arts
EA
| $138K | ﹤0.01% |
1,061
-78
| -7% | -$9.88K |
|
538
Vanguard FTSE All-World ex-US ETF
VEU
$70.7B
| $137K | ﹤0.01% |
2,520
-6,985
| -73% | -$379K |
|
539
Ulta Beauty
ULTA
$22.1B
| $136K | ﹤0.01% |
289
-163
| -36% | -$79.8K |
|
540
Moderna
MRNA
$25.4B
| $136K | ﹤0.01% |
1,119
-506
| -31% | -$67.5K |
|
541
Integer Holdings
ITGR
$4.25B
| $132K | ﹤0.01% |
1,490
| – | – |
|
|
DESP
542
DELISTED
Despegar.com
DESP
| $131K | ﹤0.01% |
18,533
| – | – |
|
|
ATVI
543
DELISTED
Activision Blizzard
ATVI
| $130K | ﹤0.01% |
1,542
+670
| +77% | +$54.2K |
|
544
Uber
UBER
$154B
| $128K | ﹤0.01% |
2,957
-512
| -15% | -$19K |
|
545
Commerce Bancshares
CBSH
$8.6B
| $126K | ﹤0.01% |
2,994
| – | – |
|
546
Franco-Nevada
FNV
$44.5B
| $125K | ﹤0.01% |
877
| – | – |
|
547
Quanta Services
PWR
$102B
| $124K | ﹤0.01% |
632
+10
| +2% | +$1.75K |
|
548
IQVIA
IQV
$39.4B
| $124K | ﹤0.01% |
551
-132
| -19% | -$26.5K |
|
549
Constellation Energy
CEG
$98.3B
| $124K | ﹤0.01% |
1,350
-106
| -7% | -$8.79K |
|
550
Travelers Companies
TRV
$77.3B
| $123K | ﹤0.01% |
710
-209
| -23% | -$36.9K |
|
Similar funds
FAM
CAM
BA
CHP
OAG
Brown Brothers Harriman & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Brown Brothers Harriman & Co held 1,359 positions worth $12.4B, up 4.1% from $11.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Brown Brothers Harriman & Co withdrew a net $416M in Q2 2023, closing 142 positions and reducing 410 holdings. Its most notable exit was Mercury Systems, an estimated $2.98M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Brown Brothers Harriman & Co opened a new position in Crane Co worth $7.31M.
- Brown Brothers Harriman & Co's largest Q2 2023 buy was Crane Co: 82,039 shares worth $7.31M.
- Brown Brothers Harriman & Co added most to Abbott in Q2 2023, an estimated $48M increase.
- Brown Brothers Harriman & Co's biggest Q2 2023 reduction was Celanese, cutting an estimated $84M.
- Brown Brothers Harriman & Co fully exited Mercury Systems in Q2 2023, selling an estimated $2.98M.
- Brown Brothers Harriman & Co's ten largest holdings make up 38% of its $12.4B portfolio in Q2 2023.
- Brown Brothers Harriman & Co opened 99 new positions and closed 142 in Q2 2023.
- Brown Brothers Harriman & Co's portfolio value rose 4.1% quarter-over-quarter to $12.4B.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2023, filed 7 Aug 2023.